Stock RGBP REGEN BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Regen BioPharma, Inc.

Equities

RGBP

US75886M3007

Market Closed - OTC Markets
Other stock markets
 14:53:15 2024-05-31 EDT 		5-day change 1st Jan Change
1 USD -.--% Intraday chart for Regen BioPharma, Inc. -4.76% +5.26%
04-24 Regen BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
02-09 Regen Biopharma, Inc. Files Provisional Patent Application for Accelerating Hematopoietic Reconstitution After an Insult or Chronic Pathology by Administration of Stem Cell Derived Endothelial Progenitor Cells or Endothelial Cells CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
REGEN BIOPHARMA, INC.
Bio Therapeutic Drugs
-.--%-4.76%+5.26%-47.37%-33.33% 4.17M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. RGBP Stock
  4. Charts Regen BioPharma, Inc.
  5. Comparison Chart